This outcome aligns with the hypothesis that the NLRP3-ASC/TMS1-Caspase 3 pathway, a critical component of the NLRP3 inflammasome, is downregulated in the NASH condition. Here, NLRP3 is linked to metabolic dysfunction-associated steatohepatitis.